Viral Gene Therapy

The potential usefulness of viral gene replacement therapy in human disease has been an exciting and extensively-studied topic in the field of skeletal muscle disease for the past 20 years. Unfortunately, while the strategy of replacing or supplementing copies of mutant gene is a straightforward concept, a number of complicating factors have been identified as gene therapy trials have progressed toward clinical studies. While some of these issues, including the immunological response to viral vectors, are issues that are encountered with all forms of gene therapy, the use of gene therapy in skeletal muscle also poses additional challenges for which treatment strategies need to be optimized. Despite these challenges, there has been substantial progress in recent years toward optimizing viral gene therapy for skeletal muscle disease in animal models, with an eye toward optimizing the safety and efficacy of viral gene therapy in humans. Skeletal muscle disorders represent considerable opportunities for investigators developing viral gene therapy strategies, due to the numerous monogenetic diseases of skeletal muscle, the clear and quantifiable clinical phenotypes, and the easy accessibility of muscle tissue. Mutations in the dystrophin gene predispose the myofiber membrane to contraction-induced membrane damage, resulting in inflammation, and myonecrosis, and progressive loss of functional muscle tissue. Several murine and canine models of dystrophinopathy have been used to study these diseases and evaluate potential therapies, including several viral gene therapy approaches. Viral gene therapy approaches have also been investigated for other disorders of skeletal muscle, including lysosomal storage disorders and congenital myopathies, and these studies have benefitted immensely from the pioneering work that was performed using dystrophinopathy models.

    Related Conference of Viral Gene Therapy

    March 18-19, 2019

    3rd International Conference on Microbial Ecology & Eco Systems

    Chicago, Illinois, USA
    (10 Plenary Forums 2 days 1 event)
    March 04-06, 2019

    9th Global Summit on Microbiology & Infectious Diseases

    Prague, Czech Republic
    May 01-02, 2019

    3rd International Conference on Medical and Clinical Microbiology

    | ANA Crowne Plaza | Kyoto, Japan
    May 17-18, 2019 |

    8th Annual Summit on Microbiology

    Philadelphia, USA
    May 20-21, 2019

    4th International Conference on Applied Microbiology and Beneficial Microbes

    | Radisson Hotel Narita | Tokyo , Japan
    June 24-25, 2019

    48th World Congress on Microbiology

    Moscow, Russia
    July 01-02, 2019

    11th International Virology Summit

    Valencia, spain
    July 26-27, 2019

    World Yeast Congress

    Vancouver | Canada
    August 12-13, 2019

    23rd World Congress on Biotechnology

    Auckland, New Zealand
    October 23-24, 2019

    2nd Global Experts Meeting on Chronic Diseases

    | Radisson Hotel Narita | Tokyo, Japan
    24-25 October, 2019

    6th World Congress and Expo on Applied Microbiology

    Rome, Italy
    November 11-12, 2019

    2nd International Conference on Microbiology

    Istanbul, Turkey

    Viral Gene Therapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in